Treating Patients With NSCLC and High PD-L1 Expression in the First Line

home / case-based-roundtable-series / treating-patients-with-nsclc-and-high-pd-l1-expression-in-the-first-line

This roundtable series evaluates the use of therapies such as monoclonal antibodies in advanced non–small cell lung cancer with high PD-L1 expression, as discussed by participants at virtual live events.